Lexston Life Sciences Corp.
Lexston Life Sciences Corp.
CSE Index:
Currency:
Lexston Life Sciences Corp. (“Lexston”) has been active in establishing strategic relationships towards executing the goal of acquiring assets and businesses. Lexston has purchased two companies that provide cannabis testing and research services.
Lexston Life Sciences Corp. (LEXT)
SEDAR Information
Company Info
Address
1150, 789 W. Pender St.
Vancouver, BC V6C 1H2
CanadaPhone
604-928-8913Fax
604-628-0129Email
admin@lexston.netWebsite
http://www.lexston.caListing date
Friday, June 25, 2021Transfer Agent
Odyssey Trust CompanyCapitalization
Issued & Outstanding:
30,309,167Reserved for Issuance:
21,750,359Company Officers
Jagdip Bal, President | Chief Executive Officer
Jatinder J Manhas, Director | Chief Financial Officer & Corporate Secretary
Clint Sharples, Director
News Releases
02/03/2023
Board of Directors appointment
24/02/2023
Change of Business Update
Bulletins
20/05/2022
2022-0522 – Consolidation - Lexston Life Sciences Corp. (LEXT)
le 20 mai/May 2022
Lexston Life Sciences Corp. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every five (5) pre-consolidated common shares.
As a result, the outstanding shares of the company will be reduced to approximately 11,746,727 common shares.
The name and symbol will not change.
Advertisement
Publicité
Upcoming Events
Benzinga Cannabis Capital Conference
Tuesday, April 11, 2023 - 8:00am to Wednesday, April 12, 2023 - 5:00pm
